Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | 10.00 | 10.00 | 11.00 | 12.50 |
| Reserves & surplus | 464.69 | 429.64 | 388.04 | 377.95 | 369.27 |
| Loan funds | |||||
| Secured loans | - | 77.33 | 66.31 | 73.23 | 40.62 |
| Unsecured loans | - | - | - | - | - |
| Total | 505.63 | 557.90 | 505.28 | 503.11 | 463.32 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 194.16 | 173.02 | 150.45 | 146.24 | 140.25 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 78.98 | 70.41 | 62.56 | 52.32 | 42.78 |
| Net block | 115.18 | 102.61 | 87.89 | 93.92 | 97.47 |
| Capital work-in-progress | - | - | - | 0.36 | - |
| Investments | 236.07 | 236.07 | 236.07 | 234.29 | 231.44 |
| Net current assets | |||||
| Current assets, loans & advances | 242.70 | 273.30 | 233.32 | 217.20 | 205.29 |
| Less : current liabilities & provisions | 88.33 | 54.09 | 52.01 | 42.66 | 70.88 |
| Total net current assets | 154.37 | 219.21 | 181.32 | 174.54 | 134.40 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 505.63 | 557.90 | 505.28 | 503.11 | 463.32 |
| Notes: | |||||
| Book value of unquoted investments | 236.07 | 236.07 | 236.07 | 234.29 | 231.44 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 140.38 | 30.40 | 11.05 | 9.20 | 9.71 |
| Number of equity sharesoutstanding (Lacs) | 4093.14 | 4093.14 | 4093.14 | 4093.14 | 4093.14 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis